An electrochemiluminescence based assay for quantitative detection of endogenous and exogenously applied MeCP2 protein variants
暂无分享,去创建一个
J. Christodoulou | J. Etzler | Katrin Rose | H. Steinkellner | A. Huber | P. Kempaiah | F. Laccone | W. Neuhaus | Alexander V. Beribisky | Mark A. Duerr | Anna Schönegger | Kathrin Hahn
[1] S. Bastianini,et al. CDKL5 protein substitution therapy rescues neurological phenotypes of a mouse model of CDKL5 disorder , 2018, Human molecular genetics.
[2] M. Justice,et al. Rett syndrome: a neurological disorder with metabolic components , 2018, Open Biology.
[3] Lan Xiao,et al. MeCP2 Deficiency in Neuroglia: New Progress in the Pathogenesis of Rett Syndrome , 2017, Front. Mol. Neurosci..
[4] A. Bird,et al. MeCP2 mutations: progress towards understanding and treating Rett syndrome , 2017, Genome Medicine.
[5] W. Kaufmann,et al. Neurobiologically-based treatments in Rett syndrome: opportunities and challenges , 2016, Expert opinion on orphan drugs.
[6] A. Bird,et al. Exclusive expression of MeCP2 in the nervous system distinguishes between brain and peripheral Rett syndrome-like phenotypes , 2016, Human molecular genetics.
[7] A. Bird,et al. Rett Syndrome: Crossing the Threshold to Clinical Translation , 2016, Trends in Neurosciences.
[8] S. Clark,et al. Methyl-CpG-binding domain proteins: readers of the epigenome. , 2015, Epigenomics.
[9] A. Bird,et al. Rett syndrome: a complex disorder with simple roots , 2015, Nature Reviews Genetics.
[10] C. Förster,et al. The pivotal role of astrocytes in an in vitro stroke model of the blood-brain barrier , 2014, Front. Cell. Neurosci..
[11] S. Cobb,et al. MeCP2 and Rett syndrome: reversibility and potential avenues for therapy. , 2011, The Biochemical journal.
[12] H. Esch. MECP2 Duplication Syndrome. , 2011 .
[13] H. Van Esch. MECP2 Duplication Syndrome , 2011, Molecular Syndromology.
[14] W. Kaufmann,et al. Rett syndrome: Revised diagnostic criteria and nomenclature , 2010, Annals of neurology.
[15] K. Riabowol,et al. REAP: A two minute cell fractionation method , 2010, BMC Research Notes.
[16] Stephen T. C. Wong,et al. MeCP2, a Key Contributor to Neurological Disease, Activates and Represses Transcription , 2008, Science.
[17] L. Villard. MECP2 mutations in males , 2007, Journal of Medical Genetics.
[18] A. Bird,et al. Reversal of Neurological Defects in a Mouse Model of Rett Syndrome , 2007, Science.
[19] C. Förster,et al. Differential susceptibility of cerebral and cerebellar murine brain microvascular endothelial cells to loss of barrier properties in response to inflammatory stimuli , 2006, Journal of Neuroimmunology.
[20] A. Bird,et al. MeCP2 Behaves as an Elongated Monomer That Does Not Stably Associate with the Sin3a Chromatin Remodeling Complex* , 2004, Journal of Biological Chemistry.
[21] H. Zoghbi,et al. Mild overexpression of MeCP2 causes a progressive neurological disorder in mice. , 2004, Human molecular genetics.
[22] R. Jaenisch,et al. Expression of MeCP2 in postmitotic neurons rescues Rett syndrome in mice. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[23] A. Bird,et al. The major form of MeCP2 has a novel N-terminus generated by alternative splicing. , 2004, Nucleic acids research.
[24] Haibin Xia,et al. The HIV Tat protein transduction domain improves the biodistribution of β-glucuronidase expressed from recombinant viral vectors , 2001, Nature Biotechnology.
[25] P. Huppke,et al. MECP2 mutations in sporadic cases of Rett syndrome are almost exclusively of paternal origin. , 2001, American journal of human genetics.
[26] S. Schwarze,et al. In vivo protein transduction: delivery of a biologically active protein into the mouse. , 1999, Science.
[27] Natalie A. Lissy,et al. Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration , 1998, Nature Medicine.
[28] S. Mboup,et al. Minerva Access is the Institutional Repository of The University of Melbourne , 2021 .
[29] J. Christodoulou,et al. MeCP2 deficiency is associated with reduced levels of tubulin acetylation and can be restored using HDAC6 inhibitors , 2014, Journal of Molecular Medicine.
[30] A. Bird,et al. A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome , 2001, Nature Genetics.